Harte Hanks acquires exclusive rights to license ADS' Medical Ailment Database
Exclusive Licensing Agreement: Harte Hanks has secured exclusive rights to license ADS Data Direct's Medical Ailment Database, enhancing its position in the healthcare marketing sector with a comprehensive, HIPAA-compliant data asset.
Enhanced Targeting Capabilities: The database offers access to triple opt-in consumers identified with specific health conditions across over 200 categories, improving targeting precision and campaign performance for clients in pharmaceuticals and medical devices.
Trade with 70% Backtested Accuracy
Analyst Views on HHS
About HHS
About the author

- Short Interest Overview: As of the end of March, Tripadvisor (TRIP) leads the communications services sector with a short interest of 26.03%, indicating a bearish market sentiment that could pressure its stock price and undermine investor confidence.
- Ranking of Short Interest: Following closely are Telesat (TSAT) and Oriental Culture Holding (OCG) with short interests of 23.95% and 22.25%, respectively, reflecting uncertainty in these companies that may impact their financing capabilities and market valuations.
- Low Short Interest Performance: In contrast, Reading International (RDIB) boasts a mere 0.50% short interest, suggesting investor confidence in its future performance, which could attract more long-term investors and enhance its market standing.
- Overall Industry Performance: The communications services select sector exhibited weak performance in Q1, with the S&P 500 logging its weakest first-quarter results since 2022, indicating a bearish market sentiment that may affect the investment appeal of related stocks.
- Earnings Performance: Harte Hanks reported a GAAP EPS of $0.30 for Q4, indicating some level of profitability despite a decline, showcasing the company's resilience in challenging conditions.
- Revenue Decline: The company's revenue for Q4 was $39.86 million, reflecting a 15.4% year-over-year decrease, primarily driven by weak market demand and intensified competition, which may exert pressure on future financial performance.
- Market Challenges: The significant revenue drop indicates that Harte Hanks is facing challenges in the market, particularly with increased competition in the digital marketing space, necessitating a reassessment of its market strategy to regain growth.
- Future Outlook: Despite the current poor financial performance, Harte Hanks must focus on cost control and business optimization to navigate potential market fluctuations and seek opportunities for growth recovery.
Earnings Performance: Harte-Hanks reported quarterly earnings of $0.13 per share, exceeding estimates and showing a year-over-year increase from $0.08. The company also surpassed revenue expectations with $47.63 million for the quarter.
Market Outlook: Despite recent earnings success, Harte-Hanks shares have underperformed compared to the S&P 500 this year, and the stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Earnings Performance: Integral Ad Science (IAS) reported quarterly earnings of $0.10 per share, exceeding estimates and showing improvement from a loss of $0.09 per share a year ago, although revenues fell short of expectations at $133.53 million.
Market Outlook: IAS shares have underperformed the market this year, with a Zacks Rank of #3 (Hold), indicating expected performance in line with the market; future stock movements will depend on management's commentary and earnings estimate revisions.
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $6.98, unchanged from the previous day, while experiencing a 5.55% loss over the past month, underperforming compared to the Business Services sector and S&P 500 gains. The company is set to release its earnings report on November 14, 2024, with expectations of a 25% year-over-year growth in earnings.
Analyst Estimates and Zacks Rank: The Zacks Consensus Estimates predict a significant decline in annual earnings and revenue for Harte-Hanks, currently holding a Zacks Rank of #3 (Hold). The Zacks Rank system indicates that stocks rated #1 (Strong Buy) have historically outperformed others, suggesting potential investment strategies based on analyst estimate changes.
Harte-Hanks Stock Performance: Harte-Hanks (HHS) closed at $7.31, down 0.41%, underperforming the S&P 500's 0.97% gain; the company is expected to report an EPS of $0.10 and revenue of $47.2 million in its upcoming earnings release.
Analyst Estimates and Zacks Rank: The Zacks Consensus Estimates predict a significant decline in full-year earnings and revenue for HHS, with the stock currently holding a Zacks Rank #3 (Hold); the Advertising and Marketing industry ranks in the top 13% among over 250 sectors.








